ATOS
Atossa Therapeutics, Inc.
$5.44-0.01 (-0.18%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
ATOSSA THERAPEUTICS, INC. (ATOS) is a publicly traded company with 2 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 2 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 13 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2026-03-27 | Quay Steven C | CEO | Award | 65,000 | $0.00 | $0 | N/A | N/A |
| 2026-03-30 | 2026-03-26 | Daniel Mark James | CFO | Award | 63,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-30 | 2026-01-20 | Quay Steven C | CEO | Award | 950,000 | $0.60 | $572,850 | N/A | N/A |
| 2025-10-21 | 2025-10-14 | Daniel Mark James | CFO | Award | 578,000 | $0.00 | $0 | N/A | N/A |
| 2025-05-22 | 2025-05-21 | Quay Steven C | CEO | Purchase | 11,239 | $0.88 | $9,890 | +1286.4% | +1246.6% |
| 2025-05-16 | 2025-05-15 | Finn Jonathan | Director | Award | 125,000 | $0.00 | $0 | N/A | N/A |
| 2025-05-16 | 2025-05-15 | Cigler Tessa | Director | Award | 125,000 | $0.00 | $0 | N/A | N/A |
| 2025-05-16 | 2025-05-15 | Remmel H. Lawrence | Director | Award | 125,000 | $0.00 | $0 | N/A | N/A |
| 2025-05-16 | 2025-05-15 | Rees Heather | CFO | Award | 543,785 | $0.00 | $0 | N/A | N/A |
| 2025-05-16 | 2025-05-15 | Quay Steven C | CEO | Award | 1,366,062 | $0.00 | $0 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.